HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study - PubMed (original) (raw)
Randomized Controlled Trial
. 2010 Aug;44(4):197-200.
doi: 10.3109/14017431003624123.
Affiliations
- PMID: 20636227
- DOI: 10.3109/14017431003624123
Free article
Randomized Controlled Trial
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Martin Prøven Bogsrud et al. Scand Cardiovasc J. 2010 Aug.
Free article
Abstract
Objective: The primary endpoint in our study was to investigate the effect of a red yeast rice (RYR) product on plasma lipids.
Design: A randomized, double-blind, placebo controlled study was performed. Patients were randomized to either RYR (HypoCol, 4 capsules/day) (n=22) or placebo (n=20) for 16 weeks. Inclusion criteria were male or female, 18-75 years, LDL-cholesterol between 3.0 and 6.0 mmol/L, fasting triglyceride level less than 4.5 mmol/L.
Results: Patients receiving RYR experienced a significant reduction in LDL-cholesterol (23.0%) and total cholesterol (15.5%) compared to placebo after 16 weeks of treatment (p<0.001).
Conclusion: The tested red yeast rice product demonstrated a significant cholesterol lowering effect compared to placebo, and was well tolerated in this Caucasian population.
Trial registration: ClinicalTrials.gov NCT00114855.
Similar articles
- Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.
Verhoeven V, Lopez Hartmann M, Remmen R, Wens J, Apers S, Van Royen P. Verhoeven V, et al. BMC Complement Altern Med. 2013 Jul 18;13:178. doi: 10.1186/1472-6882-13-178. BMC Complement Altern Med. 2013. PMID: 23866314 Free PMC article. Clinical Trial. - Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Becker DJ, et al. Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9. doi: 10.7326/0003-4819-150-12-200906160-00006. Ann Intern Med. 2009. PMID: 19528562 Clinical Trial. - Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
Heinz T, Schuchardt JP, Möller K, Hadji P, Hahn A. Heinz T, et al. Nutr Res. 2016 Oct;36(10):1162-1170. doi: 10.1016/j.nutres.2016.07.005. Epub 2016 Jul 27. Nutr Res. 2016. PMID: 27865358 Clinical Trial. - Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.
Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Gerards MC, et al. Atherosclerosis. 2015 Jun;240(2):415-23. doi: 10.1016/j.atherosclerosis.2015.04.004. Epub 2015 Apr 12. Atherosclerosis. 2015. PMID: 25897793 Review. - Red Yeast Rice for Hypercholesterolemia.
Cicero AFG, Fogacci F, Banach M. Cicero AFG, et al. Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):192-199. doi: 10.14797/mdcj-15-3-192. Methodist Debakey Cardiovasc J. 2019. PMID: 31687098 Free PMC article. Review.
Cited by
- Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial.
Tavan A, Noroozi S, Zamiri B, Gholchin Vafa R, Rahmani M, Mehdizadeh Parizi M, Ahmadi A, Heydarzade R, Montaseri M, Hosseini SA, Kojuri J. Tavan A, et al. BMC Nutr. 2022 Nov 25;8(1):138. doi: 10.1186/s40795-022-00639-z. BMC Nutr. 2022. PMID: 36434733 Free PMC article. - NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements.
Lachenmeier DW, Monakhova YB, Kuballa T, Löbell-Behrends S, Maixner S, Kohl-Himmelseher M, Waldner A, Steffen C. Lachenmeier DW, et al. Chin Med. 2012 Mar 22;7:8. doi: 10.1186/1749-8546-7-8. Chin Med. 2012. PMID: 22439629 Free PMC article. - Scientific opinion on the safety of monacolins in red yeast rice.
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS); Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, Filipič M, Frutos MJ, Galtier P, Gott D, Gundert-Remy U, Kuhnle GG, Lambré C, Leblanc JC, Lillegaard IT, Moldeus P, Mortensen A, Oskarsson A, Stankovic I, Waalkens-Berendsen I, Woutersen RA, Andrade RJ, Fortes C, Mosesso P, Restani P, Pizzo F, Smeraldi C, Wright M. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), et al. EFSA J. 2018 Aug 3;16(8):e05368. doi: 10.2903/j.efsa.2018.5368. eCollection 2018 Aug. EFSA J. 2018. PMID: 32626016 Free PMC article. - The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Liu X, Zeng X, Mahe J, Guo K, He P, Yang Q, Zhang Z, Li Z, Wang D, Zhang Z, Wang L, Jing L. Liu X, et al. Nutrients. 2023 Sep 30;15(19):4239. doi: 10.3390/nu15194239. Nutrients. 2023. PMID: 37836525 Free PMC article. Clinical Trial. - Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.
Cicero AF, Morbini M, Parini A, Urso R, Rosticci M, Grandi E, Borghi C. Cicero AF, et al. Ther Clin Risk Manag. 2016 Feb 23;12:281-6. doi: 10.2147/TCRM.S91817. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 26966368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical